InvestorsHub Logo

TPX

Followers 0
Posts 40567
Boards Moderated 4
Alias Born 10/24/2013

TPX

Re: None

Thursday, 07/27/2017 10:16:25 AM

Thursday, July 27, 2017 10:16:25 AM

Post# of 90702
$MCET APPROVED DRUG!!! *** MultiCell Technologies Phase IIB licenced candidate LAX-202 in a major deal worth USD 275 million in milestone payments and royalties.
***

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.